Verastem

Developer of small molecule inhibitors of signaling pathways for cancer therapy

placeNeedham, Massachusetts, United States calendar_todayFounded 2010 groups57 employees language verastem.com

Registered entities

Social engagement

Social engagement: 20.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

21 investors on record; lead investors include Advanced Technology Ventures, Astellas Venture Management, RTW Investments; 1 has since exited.

Investor typeCountShare
Venture capital943%
Private equity314%
Bank & private debt314%
Other / undisclosed629%

Hiring activity

Hires periodically

6 roles tracked across 4 of the last 12 months

5 Apr 2026 · Senior Clinical Trial Manager / Clinical Trial Manager · Boston

3 Mar 2026 · Medical Science Liaison / Senior Medical Science Liaison (Midwest) · Chicago

3 Mar 2026 · Medical Science Liaison/ Senior Medical Science Liaison (Pacific North West) · San Francisco

2 Mar 2026 · Senior Director, Regulatory Affairs · Boston

7 Feb 2026 · Manager/Senior Manager Statistical Programmer Programmer · Boston

Based on job postings tracked across public sources.

Recent activity

17 Jun 2026
Recognition
16 Jun 2026
Milestone
regulatory
15 Jun 2026
Event
Investor Conference Call and Webcast
Coming soon